Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -2.876M
June 30, 2026 -0.032M
March 31, 2026 -5.068M
December 31, 2025 -35.00M
September 30, 2025 -5.425M
June 30, 2025 35.57M
March 31, 2025 8.93M
December 31, 2024 -1.439M
September 30, 2024 -12.14M
June 30, 2024 4.954M
March 31, 2024 9.185M
December 31, 2023 83.66M
September 30, 2023 -20.32M
June 30, 2023 66.49M
Date Value
March 31, 2023 10.18M
December 31, 2022 12.66M
September 30, 2022 -43.39M
June 30, 2022 89.35M
March 31, 2022 36.51M
December 31, 2021 -106.49M
September 30, 2021 -242.34M
June 30, 2021 170.86M
March 31, 2021 -257.48M
December 31, 2020 67.56M
September 30, 2020 1.50M
June 30, 2020 -14.16M
March 31, 2020 86.41M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Humana, Inc. -2.069B
Centene Corp. 916.00M
CVS Health Corp. -2.787B
UnitedHealth Group, Inc. -4.573B
Elevance Health, Inc. -1.987B